JP2007513091A5 - - Google Patents

Download PDF

Info

Publication number
JP2007513091A5
JP2007513091A5 JP2006541481A JP2006541481A JP2007513091A5 JP 2007513091 A5 JP2007513091 A5 JP 2007513091A5 JP 2006541481 A JP2006541481 A JP 2006541481A JP 2006541481 A JP2006541481 A JP 2006541481A JP 2007513091 A5 JP2007513091 A5 JP 2007513091A5
Authority
JP
Japan
Prior art keywords
formula
compound
alkyl
alkoxy
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006541481A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007513091A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/039847 external-priority patent/WO2005054245A2/en
Publication of JP2007513091A publication Critical patent/JP2007513091A/ja
Publication of JP2007513091A5 publication Critical patent/JP2007513091A5/ja
Withdrawn legal-status Critical Current

Links

JP2006541481A 2003-12-01 2004-11-29 置換された5−アミノ−ピラゾロ−[4,3−e]−1,2,4−トリアゾロ[1,5−c]ピリミジンを調製するための方法 Withdrawn JP2007513091A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52592503P 2003-12-01 2003-12-01
PCT/US2004/039847 WO2005054245A2 (en) 2003-12-01 2004-11-29 Process for preparing substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines

Publications (2)

Publication Number Publication Date
JP2007513091A JP2007513091A (ja) 2007-05-24
JP2007513091A5 true JP2007513091A5 (cg-RX-API-DMAC7.html) 2007-12-20

Family

ID=34652398

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006541481A Withdrawn JP2007513091A (ja) 2003-12-01 2004-11-29 置換された5−アミノ−ピラゾロ−[4,3−e]−1,2,4−トリアゾロ[1,5−c]ピリミジンを調製するための方法

Country Status (8)

Country Link
US (3) US7235659B2 (cg-RX-API-DMAC7.html)
EP (1) EP1689749B1 (cg-RX-API-DMAC7.html)
JP (1) JP2007513091A (cg-RX-API-DMAC7.html)
AT (1) ATE377599T1 (cg-RX-API-DMAC7.html)
CA (1) CA2547248A1 (cg-RX-API-DMAC7.html)
DE (1) DE602004009962T2 (cg-RX-API-DMAC7.html)
ES (1) ES2293380T3 (cg-RX-API-DMAC7.html)
WO (1) WO2005054245A2 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1283839E (pt) * 2000-05-26 2005-08-31 Schering Corp Antagonistas do receptor a2a da adenosina
DK1678182T3 (da) * 2003-10-28 2007-06-04 Schering Corp Fremgangsmåde til fremstilling af substituerede 5-amino-pyrazolo[4,3-E]-1,2,4-triazolo-[1,5-C]pyrimidiner
JPWO2006132275A1 (ja) 2005-06-07 2009-01-08 協和醗酵工業株式会社 運動障害の予防および/または治療剤
ES2273599B1 (es) 2005-10-14 2008-06-01 Universidad De Barcelona Compuestos para el tratamiento de la fibrilacion auricular.
US8188098B2 (en) 2008-05-19 2012-05-29 Hoffmann-La Roche Inc. GPR119 receptor agonists
EP2414361A1 (en) 2009-03-31 2012-02-08 ArQule, Inc. Substituted heterocyclic compounds
US8758323B2 (en) 2009-07-30 2014-06-24 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
WO2012127472A1 (en) * 2011-03-22 2012-09-27 Mapi Pharma Ltd. Process and intermediates for the preparation of preladenant and related compounds
WO2012129381A1 (en) 2011-03-22 2012-09-27 Concert Pharmaceuticals Inc. Deuterated preladenant
WO2013024474A1 (en) * 2011-08-18 2013-02-21 Mapi Phrarma Ltd. Polymorphs of preladenant
AR117164A1 (es) 2018-11-30 2021-07-14 Merck Sharp & Dohme Derivados de amino-triazoloquinazolina 9-sustituidos como antagonistas del receptor de adenosina, composiciones farmacéuticas y su uso para el tratamiento de diversos tipos de cáncer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264901B1 (it) 1993-06-29 1996-10-17 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
PT1283839E (pt) 2000-05-26 2005-08-31 Schering Corp Antagonistas do receptor a2a da adenosina

Similar Documents

Publication Publication Date Title
JP2009536660A5 (cg-RX-API-DMAC7.html)
NO2018005I1 (no) tivozanib eller et salt eller solvat derav
JP2008074862A5 (cg-RX-API-DMAC7.html)
JP2002543185A5 (cg-RX-API-DMAC7.html)
JP2001524477A5 (cg-RX-API-DMAC7.html)
JP2007530525A5 (cg-RX-API-DMAC7.html)
WO2006098918A3 (en) Substituted gamma lactams as therapeutic agents
MY128609A (en) Ccr5 antagonists useful for treating aids.
JP2002513793A5 (cg-RX-API-DMAC7.html)
RU2004122109A (ru) Производные пирролидина и пиперидина, как антагонисты nk1
JP2007519618A5 (cg-RX-API-DMAC7.html)
WO2002080846A3 (en) Epothilone derivatives and methods for making and using the same
JP2004517099A5 (cg-RX-API-DMAC7.html)
JP2012522814A5 (cg-RX-API-DMAC7.html)
JP2012510957A5 (cg-RX-API-DMAC7.html)
NO20022124L (no) Imidazopyridinderivater som fosfodiesterase VII-inhibitorer
CA2527496A1 (en) 4-substituted derivatives of pyrazolo [3,4-d] pyrimidine and pyrrolo [2,3-d] pyrimidine and uses thereof
EA200701233A1 (ru) Производные хиназолина в качестве mtki
JP2001525394A5 (cg-RX-API-DMAC7.html)
JP2007538031A5 (cg-RX-API-DMAC7.html)
JP2006515600A5 (cg-RX-API-DMAC7.html)
NO20062491L (no) Benzoksazinderivter og deres anvendelse
WO2006003500A8 (en) Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h`1,2,4!triazin-2-yl!-benzamide derivatives by deprotecting the hydroxyl-protected precursers
JP2004523478A5 (cg-RX-API-DMAC7.html)
JP2008520662A5 (cg-RX-API-DMAC7.html)